- La Jolla Pharmaceutical press release (NASDAQ:LJPC): Q1 GAAP EPS of $0.00 misses by $0.01.
- Revenue of $10.43M (-69.4% Y/Y) misses by $2.67M.
- “We are pleased to report that La Jolla continues to grow net product sales and generate positive operating cash flow,” said Larry Edwards, President and Chief Executive Officer of La Jolla. “La Jolla’s focus remains on growing its GIAPREZA and XERAVA franchises while increasing operating cash flow.”
La Jolla Pharmaceutical GAAP EPS of $0.00 misses by $0.01, revenue of $10.43M misses by $2.67M
Recommended For You
More Trending News
About INVA Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
INVA | - | - |
Innoviva, Inc. |